턱밑 지방 치료 시장 : 치료 유형별, 제품별, 최종 용도별 - 세계 예측(2024-2032년)

Submental Fat Treatment Market size is projected to record an 11.7% CAGR from 2024 to 2032, driven by the increasing popularity of aesthetic procedures worldwide. This treatment targets the fat under the chin for enhancing facial contours and achieving a more youthful appearance.

Advancements in non-invasive techniques, such as injectables and laser therapies are also helping in meeting this demand effectively. With the evolving aesthetic preferences, patients can seek more personalized and effective options for submental fat reduction, further reflecting the ongoing trends towards minimally invasive yet impactful cosmetic enhancements. According to the Aesthetic Society's 2022 report, Americans spent over $11.8 billion on aesthetic procedures, marking a 2% increase from 2021. The surging interest in non-invasive cosmetic enhancements will also favor the industry growth.

The overall market is segregated into treatment type, product, end-use, and region.

In terms of treatment type, the submental fat treatment market from the minimally invasive treatments segment is expected to record a significant CAGR from 2024 to 2032. Minimally invasive treatments employ techniques, such as injections or laser therapy to target and break down fat cells under the chin for providing a non-surgical alternative to traditional liposuction. Patients are also favoring these treatments due to their proven effectiveness and minimal recovery periods.

By end-use, the submental fat treatment industry from the dermatology clinics segment is projected to rise from 2024 to 2032, driven by the strong presence of several treatments involving various techniques like injections or non-invasive procedures to target and eliminate fat cells. Lately, dermatology clinics are researching and developing new methods to enhance treatment efficacy and patient satisfaction. In addition, they are also incorporating advanced technologies and innovative therapies to further refine these procedures.

Regionally, the Asia Pacific submental fat treatment market size is projected to exhibit robust growth between 2024 and 2032, fueled by regulatory approvals and the expansion of treatment options. Clinics across the region are adapting to regulatory changes and securing approvals for new technologies and techniques. These developments are broadening the range of available treatments for improving accessibility for patients seeking cosmetic enhancements. The ongoing improvements in the quality and accessibility of submental fat treatments will also favor regional industry growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Rising prevalence of obesity
  • 3.2.3 Increasing awareness about dermatological procedures
  • 3.2.4 Rising demand for aesthetic procedures
  • 3.2.5 Advancements in technology
  • 3.2.6 Industry pitfalls & challenges
  • 3.2.7 High cost of treatment
  • 3.2.8 Side effects of treatments
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Surgical treatments
• 5.3 Minimally invasive treatments
• 5.4 Non-invasive treatments

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Surgical rejuvenation
• 6.3 Targeted liposuction
• 6.4 Laser ablation
• 6.5 Other products

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Dermatology clinics
• 7.4 Medical spa
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Apax Partners
• 9.2 ALASTIN Skincare, Inc.
• 9.3 Boston Scientific Corporation
• 9.4 Bausch Health Companies Inc.
• 9.5 Cutera, Inc.
• 9.6 El.En. S.p.A.
• 9.7 Hahn & Company
• 9.8 Huadong Medicine Co., Ltd.
• 9.9 Merz Pharma
• 9.10 Sciton, Inc.
• 9.11 SharpLight Technologies Inc.
• 9.12 Sisram Medical Ltd
• 9.13 TRIA BEAUTY
• 9.14 Venus Concept Inc.
• 9.15 Vitruvian Partners LLP